Sign up Australia
Proactive Investors - Run By Investors For Investors

Novogen, Coretrack among Tuesday’s volume leaders

Novogen, Coretrack among Tuesday’s volume leaders

Tuesday’s leading volume stocks on the ASX.

NameCodeLastChangeVolume
Novogen Limited ASX:NRT $0.29 -30.1% 63,437,330
Coretrack Limited ASX:CKK $0.01 -9.1% 38,296,086
Axxis Technology Group ASX:AYG $0.001 -50% 29,860,746
Genetic Technologies ASX:GTG $0.042 -6.7% 25,631,735
Telstra Corporation ASX:TLS $6.19 0.3% 21,906,632
Fortescue Metals Group ASX:FMG $1.87 -1.1% 21,473,324
International Goldfields ASX:IGS $0.001 0% 17,500,000
SmartTrans Holdings ASX:SMA $0.023 9.5% 15,522,618
Environmental Clean Technologies ASX:ESI $0.011 10% 14,721,111
Stonehenge Metals ASX:SHE $0.029 -6.5% 14,649,339

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

View full NRT profile View Profile

Novogen Ltd Timeline

Newswire
August 05 2015

Related Articles

picture of drug research
August 23 2017
With US licensee driving the Phase 1 trials of Sareum's lead candidate, SRA737, the focus moves to TYK2, a compound that is targeting psoriasis, rheumatoid arthritis, and other autoimmune disorders
Woman with tissue facing pollen
October 20 2017
Allergy, which saw its market share grow by a percentage point to 13%, is in a strong financial position, with £22.1mln in the bank

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use